The effect of high-dose insulin analog initiation therapy on lipid peroxidation products and oxidative stress markers in type 2 diabetic patients

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Tuzcu, Hazal ^a   Aslan, Ibrahim ^b   Aslan, Mutay ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b Antalya Education and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GLUCOSE LEVEL; CONTINUOUS GLUCOSE MONITORING; DIABETIC PATIENT; INHIBITORY EFFECT; LIPID PEROXIDATION; OXIDATIVE STRESS MARKERS; RADICAL FORMATION; TYPE 2 DIABETES MELLITUS;

BLOOD; DRUG PRODUCTS; FREE RADICALS; GLUCOSE; INSULIN; LIPIDS; OXIDATIVE STRESS;

PATIENT TREATMENT;

3 NITROTYROSINE; CARBONYL DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; METFORMIN; NITRATE; NITRITE; PROSTAGLANDIN F2 ALPHA; SULFONYLUREA DERIVATIVE; 3-NITROTYROSINE; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; BIOLOGICAL MARKER; DRUG DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; INSULIN; TYROSINE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DRUG MEGADOSE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN TREATMENT; LIPID PEROXIDATION; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PROTEIN CARBONYLATION; AGED; BLOOD; DRUG COMBINATION; DRUG EFFECT; METABOLISM; MIDDLE AGED; URINE;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DINOPROST; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; LIPID PEROXIDATION; MALE; METFORMIN; MIDDLE AGED; NITRATES; NITRITES; OXIDATIVE STRESS; PROTEIN CARBONYLATION; SULFONYLUREA COMPOUNDS; TYROSINE;

EID: 84876532742     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/513742     Document Type: Article

References (32)

1. UK Prospective Diabetes Study (UKPDS) Group, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 352 9131 837 853 2-s2.0-0032511583 10.1016/S0140-6736(98)07019-6 (Pubitemid 28416718)
2. The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 1993 329 977 986
3. Ceriello A., Hanefeld M., Leiter L., Monnier L., Moses A., Owens D., Tajima N., Tuomilehto J., Postprandial glucose regulation and diabetic complications. Archives of Internal Medicine 2004 164 19 2090 2095 2-s2.0-6944252200 10.1001/archinte.164.19.2090 (Pubitemid 39410797)
4. Ceriello A., Esposito K., Piconi L., Ihnat M. A., Thorpe J. E., Testa R., Boemi M., Giugliano D., Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008 57 5 1349 1354 2-s2.0-48449098502 10.2337/db08-0063
5. Brownlee M., Hirsch I. B., Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. Journal of the American Medical Association 2006 295 14 1707 1708 2-s2.0-33645732339 10.1001/jama.295.14.1707
6. Chiasson J. L., Josse R. G., Gomis R., Hanefeld M., Karasik A., Laakso M., Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients with Impaired Glucose Tolerance: The STOP-NIDDM Trial. Journal of the American Medical Association 2003 290 4 486 494 2-s2.0-0038455703 10.1001/jama.290.4.486 (Pubitemid 37430502)
7. De Caterina R., Endothelial dysfunctions: common denominators in vascular disease. Current Opinion in Lipidology 2000 11 1 9 23 2-s2.0-0034114708 10.1097/00041433-200002000-00003 (Pubitemid 30148193)
8. Ceriello A., Taboga C., Tonutti L., Quagliaro L., Piconi L., Bais B., Da Ros R., Motz E., Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 2002 106 10 1211 1218 2-s2.0-0037015288 10.1161/01.CIR.0000027569.76671.A8 (Pubitemid 34988638)
9. Brownlee M., Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 6865 813 820 2-s2.0-0035856980 10.1038/414813a (Pubitemid 34000785)
10. Rodbard D., Optimizing display, analysis, interpretation and utility of self-monitoring of blood glucose (SMBG) data for management of patients with diabetes. Journal of Diabetes Science and Technology 2007 1 62 71
11. McGarraugh G., The chemistry of commercial continuous glucose monitors. Diabetes technology & therapeutics 2009 11 S17 S24 2-s2.0-70349240853
12. Rodbard H. W., Blonde L., Braithwaite S. S., Brett E. M., Cobin R. H., Handelsman Y., Hellman R., Jellinger P. S., Jovanovic L. G., Levy P., Mechanick J. I., Zangeneh F., Parkin C. G., American association of clinical endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocrine Practice 2007 13 1 1 68 2-s2.0-77649091668
13. Kupesiz A., Celmeli G., Dogan S., Antmen B., Aslan M., The effect of hemolysis on plasma oxidation and nitration in patients with sickle cell disease. Free Radical Research 2012 46 883 890
14. Monnier L., Mas E., Ginet C., Michel F., Villon L., Cristol J. P., Colette C., Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. Journal of the American Medical Association 2006 295 14 1681 1687 2-s2.0-33645745733 10.1001/jama.295.14.1681
15. Wentholt I. M. E., Kulik W., Michels R. P. J., Hoekstra J. B. L., DeVries J. H., Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia 2008 51 1 183 190 2-s2.0-36649006065 10.1007/s00125-007-0842-6 (Pubitemid 50002199)
16. Siegelaar S. E., Barwari T., Kulik W., Hoekstra J. B., DeVries H. J., No relevant relationship between glucose variability and oxidative stress in well-regulated type 2 diabetes patients. Journal of diabetes science and technology 2011 5 1 86 92 2-s2.0-79957989692
17. Odetti P., Garibaldi S., Noberasco G., Aragno I., Valentini S., Traverso N., Marinari U. M., Levels of carbonyl groups in plasma proteins of type 2 diabetes mellitus subjects. Acta Diabetologica 1999 36 4 179 183 2-s2.0-0033255520
18. Çakatay U., Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes and Metabolism 2005 31 6 551 557 2-s2.0-29344475463 10.1016/S1262-3636(07)70230-6 (Pubitemid 43001172)
19. Pan H. Z., Zhang H., Chang D., Li H., Sui H., The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. British Journal of Ophthalmology 2008 92 4 548 551 2-s2.0-41849133569 10.1136/bjo.2007.130542 (Pubitemid 351497989)
20. Pan H. Z., Zhang L., Guo M. Y., Sui H., Li H., Wu W. H., Qu N. Q., Liang M. H., Chang D., The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetologica 2010 47 1 S71 S76 2-s2.0-78751577772 10.1007/s00592-009-0128-1
21. Sarkar P., Kar K., Mondal M. C., Chakraborty I., Kar M., Elevated level of carbonyl compounds correlates with insulin resistance in type 2 diabetes. Annals of the Academy of Medicine Singapore 2010 39 12 909 912 2-s2.0-79251513977
22. Pereira E. C., Ferderbar S., Bertolami M. C., Faludi A. A., Monte O., Xavier H. T., Pereira T. V., Abdalla D. S. P., Biomarkers of oxidative stress and endothelial dysfunction in glucose intolerance and diabetes mellitus. Clinical Biochemistry 2008 41 18 1454 1460 2-s2.0-55949089360 10.1016/j.clinbiochem.2008.08.074
23. Ceriello A., Mercuri F., Quagliaro L., Assaloni R., Motz E., Tonutti L., Taboga C., Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 2001 44 7 834 838 2-s2.0-0034937703 10.1007/s001250100529 (Pubitemid 32642455)
24. Ceriello A., Quagliaro L., Catone B., Pascon R., Piazzola M., Bais B., Marra G., Tonutti L., Taboga C., Motz E., Role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care 2002 25 8 1439 1443 2-s2.0-0036674993 10.2337/diacare.25.8.1439 (Pubitemid 41071158)
25. Predescu D., Predescu S., Malik A. B., Transport of nitrated albumin across continuous vascular endothelium. Proceedings of the National Academy of Sciences of the United States of America 2002 99 21 13932 13937 2-s2.0-0037108820 10.1073/pnas.212253499 (Pubitemid 35215483)
26. Zheng F., Lu W., Jia C., Li H., Wang Z., Jia W., Relationships between glucose excursion and the activation of oxidative stress in patients with newly diagnosed type 2 diabetes or impaired glucose regulation. Endocrine 2010 37 1 201 208 2-s2.0-75949130069 10.1007/s12020-009-9296-6
27. Monnier L., Colette C., Mas E., Michel F., Cristol J. P., Boegner C., Owens D. R., Regulation of oxidative stress by glycaemic control: Evidence for an independent inhibitory effect of insulin therapy. Diabetologia 2010 53 3 562 571 2-s2.0-77949263068 10.1007/s00125-009-1574-6
28. Sakamoto M., Inoue G., Tsuyusaki K., Usui K., Watanabe M., Irie J., Atsuda K., Yamada S., Comparison of oxidative stress markers in type 2 diabetes: Basal bolus therapy versus twice daily premixed insulin analogs. Internal Medicine 2010 49 5 355 359 2-s2.0-77749321076 10.2169/internalmedicine.49.2725
29. Monnier L., Colette C., Michel F., Cristol J. P., Owens D. R., Insulin therapy has a complex relationship with measure of oxidative stress in type 2 diabetes: a case for further study. Diabetes/Metabolism Research and Reviews 2011 27 4 348 353 2-s2.0-79955746931 10.1002/dmrr.1174
30. Nunes S. F., Figueiredo I. V., Soares P. J., Costa N. E., Lopes M. C., Caramona M. M., Semicarbazide-sensitive amine oxidase activity and total nitrite and nitrate concentrations in serum: Novel biochemical markers for type 2 diabetes? Acta Diabetologica 2009 46 2 135 140 2-s2.0-67349191478 10.1007/s00592-008-0070-7
31. Catalano M., Carzaniga G., Perilli E., Jun T., Scandale G., Andreoni S., Carotta M., Basal nitric oxide production is not reduced in patients with noninsulin-dependent diabetes mellitus. Vascular Medicine 1997 2 4 302 305 2-s2.0-0031421377 (Pubitemid 28212097)
32. Francesconi F., Mingardi R., DeKreutzenberg S., Avogaro A., Effect of metabolic control on nitrite and nitrate metabolism in type 2 diabetic patients. Clinical and Experimental Pharmacology and Physiology 2001 28 7 518 521 2-s2.0-0034960283 10.1046/j.1440-1681.2001.03479.x (Pubitemid 32588426)